GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … Post author:Sam Post published:October 22, 2017 Post category:BioPharma Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace You Might Also Like Most Common Mistake Scientists Make When Applying for a Job July 19, 2017 Guided Therapeutics Ships Five LuViva Advanced Cervical Scans To Chinese Partner April 12, 2017 Gates and His Rich Buddies Back Exicure's $11.2M Funding Round November 5, 2017
